Home
|
Site Map
|
Search
|
Contact Us
|
Sign In
Corporate
Technology
Investors
News
Mission Statment
Management & Advisory Teams
Licensing & Co-Development Opportunities
FABACs
Products
Publications
Patents
Animated Illustrations
Latest News
November 24, 2006
FABACs and Aramchol Status Report
The most advanced compound in the series of proprietary fatty acid bile-acid conjugates is Aramchol , which is currently in preclinical studies.
Page:
1
2